US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: A Biotech Leader with a 23.99% Upside Potential

Genmab A/S (NASDAQ: GMAB), a pioneering biotechnology company based in Denmark, has been capturing the attention of investors due to its robust pipeline of innovative therapies and strategic partnerships with..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Strong Upside Potential of 21.89%

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector with a robust market capitalization of $14.12 billion. Specializing in the development of therapies for chronic and life-threatening diseases,..

Natera, Inc. (NTRA) Stock Analysis: Understanding the 19.44% Upside Potential and Analyst Confidence

Natera, Inc. (NTRA), a key player in the healthcare sector specializing in diagnostics and research, is garnering significant attention from investors. With a market capitalization of $22.73 billion, the Austin,..

Insmed Incorporated (INSM) Stock Analysis: Exploring Growth Potential with a 12.55% Upside in Biotech

Insmed Incorporated (NASDAQ: INSM) is capturing the attention of investors due to its significant presence in the biotechnology sector, a market cap of $27.88 billion, and promising growth prospects. Specializing..

Illumina, Inc. (ILMN) Stock Analysis: Evaluating the 10.07% Potential Upside

Illumina, Inc. (ILMN), a leading player in the healthcare sector’s diagnostics and research industry, presents an intriguing investment opportunity. With a market cap of $16.11 billion, Illumina has carved out..

Insulet Corporation (PODD) Stock Analysis: A Strong Buy with Potential Upside and Impressive Revenue Growth

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, specializes in innovative medical devices that have revolutionized insulin delivery systems. The company’s Omnipod platform has become a critical..

Quest Diagnostics (DGX) Investor Outlook: Analyzing a 4.42% Potential Upside in the Healthcare Sector

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specializes in diagnostic testing and services, providing a broad spectrum of diagnostic information services across the United States..

Danaher Corporation (DHR) Stock Analysis: Unpacking a 16.12% Upside Potential with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a leading player in the healthcare sector, specializes in diagnostics and research. With a substantial market capitalization of $151.66 billion, Danaher is a formidable entity within..

Humana Inc. (HUM) Investor Outlook: Evaluating the Healthcare Giant with a $36 Billion Market Cap

Investors in the healthcare sector frequently look to Humana Inc. (NYSE: HUM) as a stalwart with a solid reputation for delivering comprehensive healthcare plans in the United States. With a..

Labcorp Holdings Inc. (LH) Stock Analysis: A Healthcare Giant with a 5.60% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a prominent player in the healthcare sector, has carved out a significant niche in the diagnostics and research industry. With a market capitalization of $23.12..

Hologic, Inc. (HOLX) Stock Analysis: Exploring the 7.53% Potential Upside for Healthcare Investors

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, continues to capture the attention of investors with its robust portfolio in diagnostics and medical imaging, particularly for women’s..

Alcon Inc. (ALC) Stock Analysis: Exploring an 18.99% Potential Upside

Alcon Inc. (NYSE: ALC), a global leader in eye care products, presents an intriguing opportunity for investors looking to venture into the healthcare sector. As a Swiss-based company with a..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Deep Dive into Potential Upside and Analyst Ratings

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector and a leading player in the specialty and generic drug manufacturing industry, offers a compelling case for investors assessing..

Medtronic plc (MDT) Stock Analysis: A Healthcare Giant with a 6.18% Upside Potential

Medtronic plc (MDT), a cornerstone in the healthcare sector, is making waves with its solid market presence and promising growth potential. With a market capitalization of $118.79 billion, Medtronic stands..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 21.49% Potential Upside in Animal Health Investments

Zoetis Inc. (NYSE: ZTS) stands out as a pivotal player in the healthcare sector, particularly within the specialized niche of animal health. With an impressive market capitalization of $69.41 billion,..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Medical Devices Market with a 2.98% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking exposure to the burgeoning orthopedic and..

Novartis AG (NVS) Stock Analysis: Key Insights into the Swiss Pharmaceutical Giant’s Performance and Potential

Novartis AG (NYSE: NVS), a stalwart in the global healthcare sector, continues to draw investor interest with its strategic focus on innovation and robust financial health. Headquartered in Basel, Switzerland,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: A Robust Dividend Yield with a 9.60% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK) remains a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With roots tracing back to 1781, this..

Stryker Corporation (SYK) Stock Analysis: Exploring 9.65% Potential Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, continues to capture the attention of investors with its robust market presence and promising future growth prospects. With a..

ResMed Inc. (RMD) Stock Analysis: Exploring Growth Potential and Investor Confidence Amidst Strong Revenue Growth

ResMed Inc. (NYSE: RMD), a titan in the healthcare sector, specializes in medical instruments and supplies, with a strong emphasis on respiratory care. With a market capitalization of $43.01 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds